effect of enterohepatic circulation on drug half-life
5:02
PK & property differences of biologics & small molecule drugs
12:59
discovery of nivasorexant, an orexin-1 receptor antagonist
10:26
FDA approval of REZDIFFRA (resmetirom) for NASH/MASH treatment
1:01:02
MONDAY NIGHT LIVE with Dr. Berry and Nurse Neisha
11:16
FDA approval of EXBLIFEB - cefepime & enmetazobactam
28:58
The BIG SIGNS That Relationship Won't Last - God Warns | C.S Lewis Sermons
10:00
FDA approval of TRYVIO - aprocitentan
14:05